{"name":"Orum Therapeutics USA, Inc.","slug":"orum-therapeutics-usa-inc","ticker":"","exchange":"","domain":"","description":"Orum Therapeutics USA, Inc. is a biotechnology company focused on developing innovative therapies for serious diseases. The company's lead candidate, ORM-5029, was discontinued, indicating a shift in their research and development focus.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFB5bkc2a3NnR1RyeTQzdWRjQWkzTERMWDFaRk1MUHJBTHBDQUF5T19kSXdFZkZQNHFZUkpCWVF3S2IyaWNvVTZ3OGc3Wm05c0toV3dSbzYtZGVtcEQxUWNsWktn?oc=5","date":"2026-04-06","type":"pipeline","source":"TradingView","summary":"ETFs Investing in Orum Therapeutics, Inc. Stocks - TradingView","headline":"ETFs Investing in Orum Therapeutics, Inc. Stocks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1mU3gzT241RE4wcU42WFpSN3ZlQ3F6b0lVaVF3UmoySG9KeFdETkVTODZTMEdXRjZ2S1ZiLXI3UEJHa0lGV3B5ckFVejBZRXNWN3l5ell5YTk5cjhmd20xWE1hbFAzeUpZR082ekZ30gFyQVVfeXFMTk5meWlXcXhNZXBWV2l6NGgydXQyOFgtYmozeWpaOVgzakZUU3BRS0dWdVE5OUY5dmJVT285YUVaVU1ycmlNbElvdlEwRWNRd00wNzU3ZmxnY1lOZk9Nc0s2UGszVHpJb1VNOFVLZktUSjVR?oc=5","date":"2026-01-22","type":"pipeline","source":"koreabiomed.com","summary":"[JPM 2026] Big pharma eyes ‘post-ADC’ solutions as Orum’s DAC draws interest - koreabiomed.com","headline":"[JPM 2026] Big pharma eyes ‘post-ADC’ solutions as Orum’s DAC draws interest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFByZGhHdnRKdWp0OWl2MjNZOHhtVF85XzRJOFpoRUpnYnBXRDhKRk5qREZCam1QeEJmLXNjUzd6SmpXNl9pd294NHVVMFhjR2RfU2dvTVJVbU9DVjJhOGFMc3ByNnBoSm84S2RSX3BJOGtjNWlxMTRTU2Zn?oc=5","date":"2025-12-20","type":"trial","source":"Wiley","summary":"Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials - Wiley","headline":"Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer tri","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNSlRiWFJxd2pHVTRTSWd6TWRmc052ZXVsVDhERy0zbEZ1MmhQNGFSanpFdXN6em5LQ0l1bUJpMGpRMlFFc1NQR2xRZ2gtX2hoWWFHN1NWYk5RVGdINWtpckprZ1ZOcDV3dFBmekJicDlXVnFGa2ROcktfcmdvaXU3QU5GYldIWEUxRDlybGZkclgxZVU?oc=5","date":"2025-12-18","type":"pipeline","source":"BioPharma Dive","summary":"Orum, a biotech marrying ADCs with protein degraders, captures $100M in funding - BioPharma Dive","headline":"Orum, a biotech marrying ADCs with protein degraders, captures $100M in funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxQZWNKSDJyMlp2aTFmRTNrWjBUclI2UEV4b0tZUmIzU21nNG1QNHJZQnFIV29HZWpXdDU1VWNhR2R1eEJXdE91TGFHenpvdGNoUVE5MzZlUThVTDNVbEVKWFRBeXM2RlVtOW5Lb0ZBc1lERzBSX3hkSGNpWExISXlYZnpVc0VjQmRuWVBhTFNVUGtVbWNCdFB5ZDhEQnc2N1h4RGt2VEtkYk9KckFqM18za3ZzTk0zd2RWcklVeGozYmk2WGg4aUlSTzV4TDMzYlVic1h3WEo5alhUQ0VycXZ6S1RtbVlRdkk3bzE5Tm5ha1RXZG1OX011MWFIQU16TGNtZHk0UFdpMThveXJfR0hBYnhWRUlrZTRnVHo5M2pNTXc0ZFVPX1BaYTRjVi1RTmpHQWhPSzdHbVY?oc=5","date":"2025-12-18","type":"pipeline","source":"Business Wire","summary":"Orum Therapeutics Secures Approximately US$100 Million to Accelerate Development of Leading Degrader Antibody Conjugate Programs to Treat Serious Diseases - Business Wire","headline":"Orum Therapeutics Secures Approximately US$100 Million to Accelerate Development of Leading Degrader Antibody Conjugate ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNNmZIOVF4Y2d0dTBEbGhLWHlHTF9FOUNKNjZLQ1laWVphc3lVdExBbU1MQnBmSUpFZmtKallRdmRhLTJfY29ka3dlQW9hQ045dUhYU09PZUtzc1B4SFlFc1paRUF2Y2NPQU5ISzZ2Y3BPS3RkRmptMk40OWFQTDNnRnBvcGtRX04x?oc=5","date":"2025-12-03","type":"pipeline","source":"조선일보","summary":"BMS Executive: AI to Reshape Pharmaceutical, Biotech Industries - 조선일보","headline":"BMS Executive: AI to Reshape Pharmaceutical, Biotech Industries - 조선일보","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPR2VpOHFiTmdVZ0pCZldIT2lNNHlyREN0bU40elkxekhXUHFyeFJvRm9iZDhTbHgwRm5sYlNzRmpYOUdFN0dnRjlPTkhXb2xsTHBGb2VLaWdnTWk4NWlxY2gzTnY5aTFvdlR0MmtxcFJPZEFCMGdXQ25VLURMVmRKOHdlZElNNmplSjdxV29UX2VBQ1luc2RJMVlvZ0x2czYyZWtkTlB6dDJhRTFfS2pORDYzZEQ?oc=5","date":"2025-10-17","type":"trial","source":"Endpoints News","summary":"Boehringer Ingelheim names global obesity leader; Calico taps AbbVie vet for discovery role - Endpoints News","headline":"Boehringer Ingelheim names global obesity leader; Calico taps AbbVie vet for discovery role","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQejVOQWEzZlFvQV9sYlB3ZkpsbC1MdVk2aDBLa2gxOVF2S3RiT0dHUURIOWc3VVUzWGgyNHVOUVFfVW5WYmdiNlYtdVp0M2k3M25Rb2JldERDQTZnVGhiSUZveDlGOGRRdVB4cHhIRWNwXzRtU0YyeHlZWW5YeHB3WjBwWVhBY1pWT09oek1heGhzNnVuMHVibGl6Vy03YUk?oc=5","date":"2025-09-09","type":"pipeline","source":"BioWorld News","summary":"Biopharma IPO activity slows, but 2025 returns are surging - BioWorld News","headline":"Biopharma IPO activity slows, but 2025 returns are surging","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFA0Rkx1TTdkc2ctWHVac3NWMUtNamZuNVRYWjlWM2Jyam5oaG5FNkpKVWZnckR0MVlaVVEyZ3hHQ1luTzFYSmUxSFBNang1NEZ3RzhELUpBMlhyS18ydzUxdk1DN05ZVlpnVVZDcVF30gFyQVVfeXFMTWNTVWdrOEhkb1RyaS00X3ZMb0dxd3g1bGtidm1sY2R3elMtV2g1bk4wNi1XWjJnWHJmUmtRRk8tSVg0UFc4dUVHajMyOThiUVc5LVlCcC1rWXlucTJRZ0R5NFhTYWt1ZVpialNFc1NlZmh3?oc=5","date":"2025-04-28","type":"trial","source":"koreabiomed.com","summary":"Orum shares plummet after termination of US breast cancer trial - koreabiomed.com","headline":"Orum shares plummet after termination of US breast cancer trial","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNdFFpWjdocWpLaXRERmJDRXl4OUJCUDhDVFFraDdnVHhWUUlBMDlDc1p5VlZFVWNSX1BpaEdDWHhaQnZlZ096TFNaVEtxUUp5eUcwUV9XVDdvMHF2WmFtRldBZ2RRdnNNQWJhWmh1cmNPUm9nYzl0SXhsMGFHMjhFRDNHaHZneFZDTUktQlNlNVZNUQ?oc=5","date":"2024-07-16","type":"deal","source":"Fierce Biotech","summary":"Vertex mines for more gene editing riches with $15M Orum licensing deal - Fierce Biotech","headline":"Vertex mines for more gene editing riches with $15M Orum licensing deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPcGNrR0FUX0ZoME5Ualk2cGpWRlA1WTQ2bXhqOVprbkx2UmsyODdEMksxOUZyWUstejZGTlh2Qi10NkdkeDBnMjFQX2Q1R1VzeWc5MDJEZnQya3Azd3dJcC13WlpQUk04SVdlb3R0clFKRnNzZVVtdXNUQkpfeElGaGN6TGsxUmcwd08tbi1VcUpGZy1sVjBHbm5Ca0R3S290bDUzcGlzc2YzOXpBRkNKN0RBdw?oc=5","date":"2024-07-16","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Replacing Chemo: Vertex, Orum Launch Up to $945M+ DAC Collaboration - Genetic Engineering and Biotechnology News","headline":"Replacing Chemo: Vertex, Orum Launch Up to $945M+ DAC Collaboration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQdXBuLUVSbEE4V1ZzWUtxWnVHZ0c5NjhoOGpHcXdzYTI0X0xBaXZiZ1lSQS1vQVMtQUw3TXBrYWpFNmNnQ2dkNGQ4YUVDNU1OWmZZQjdZRTlnR1ZEeHVpQldsMm1BeTBLa01rZzd1RmYxeW5jN2RuM0RDZHFUdmFGcnZvc0w4NllMeTNBZlp5SHd5Tkc4RFRXc0lueGRkazJDRHRBeA?oc=5","date":"2023-11-07","type":"deal","source":"Contract Pharma","summary":"BMS Acquires Orum’s ADC Protein Degrader for $100M Upfront - Contract Pharma","headline":"BMS Acquires Orum’s ADC Protein Degrader for $100M Upfront","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}